This document provides an overview of pulmonary tuberculosis. It discusses that tuberculosis is caused by Mycobacterium tuberculosis and primarily affects the lungs, causing symptoms like cough and weight loss. Diagnosis involves sputum smear examination and chest x-rays. Treatment follows the DOTS strategy of directly observed therapy with a combination of drugs over 6-9 months. Nursing care focuses on airway clearance, treatment adherence, nutrition, and educating patients on prevention.
Pulmonary TB is a bacterial infection of the lungs that can cause a range of symptoms, including chest pain, breathlessness, and severe coughing. Pulmonary TB can be life-threatening if a person does not receive treatment. People with active TB can spread the bacteria through the air.
Pulmonary TB is a bacterial infection of the lungs that can cause a range of symptoms, including chest pain, breathlessness, and severe coughing. Pulmonary TB can be life-threatening if a person does not receive treatment. People with active TB can spread the bacteria through the air.
Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic
More than 5.7 million new cases of TB (all forms, both pulmonary and extra-pulmonary) were reported to the World Health Organization (WHO) in 2013; 95% of cases were reported from developing countries
Latest figures from 20151 indicate an estimated 10.4 million people had TB, and 1.8 million people died (1.4 million HIV negative and 400 000 HIV positive).
Of further concern is that 480 000 cases of multidrug-resistant (MDR) TBa and a further 100 000 that were estimated to be rifampicin-resistant (RR) TB have occurred in the same period.
Pneumonia is an inflammatory condition of the lung affecting primarily the small air sacs known as alveoli. Typically symptoms include some combination of productive or dry cough, chest pain, fever, and trouble breathing. Severity is variable.
Pneumonia is usually caused by infection with viruses or bacteria and less commonly by other microorganisms, certain medications and conditions such as autoimmune diseases. Risk factors include cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, diabetes, heart failure, a history of smoking, a poor ability to cough such as following a stroke, and a weak immune system. Diagnosis is often based on the symptoms and physical examination. Chest X-ray, blood tests, and culture of the sputum may help confirm the diagnosis. The disease may be classified by where it was acquired with community, hospital, or health care associated pneumonia.
Vaccines to prevent certain types of pneumonia are available. Other methods of prevention include handwashing and not smoking. Treatment depends on the underlying cause. Pneumonia believed to be due to bacteria is treated with antibiotics. If the pneumonia is severe, the affected person is generally hospitalized. Oxygen therapy may be used if oxygen levels are low.
Pneumonia affects approximately 450 million people globally (7% of the population) and results in about four million deaths per year. Pneumonia was regarded by William Osler in the 19th century as "the captain of the men of death". With the introduction of antibiotics and vaccines in the 20th century, survival improved. Nevertheless, in developing countries, and among the very old, the very young, and the chronically ill, pneumonia remains a leading cause of death. Pneumonia often shortens suffering among those already close to death and has thus been called "the old man's friend"
Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic
More than 5.7 million new cases of TB (all forms, both pulmonary and extra-pulmonary) were reported to the World Health Organization (WHO) in 2013; 95% of cases were reported from developing countries
Latest figures from 20151 indicate an estimated 10.4 million people had TB, and 1.8 million people died (1.4 million HIV negative and 400 000 HIV positive).
Of further concern is that 480 000 cases of multidrug-resistant (MDR) TBa and a further 100 000 that were estimated to be rifampicin-resistant (RR) TB have occurred in the same period.
Pneumonia is an inflammatory condition of the lung affecting primarily the small air sacs known as alveoli. Typically symptoms include some combination of productive or dry cough, chest pain, fever, and trouble breathing. Severity is variable.
Pneumonia is usually caused by infection with viruses or bacteria and less commonly by other microorganisms, certain medications and conditions such as autoimmune diseases. Risk factors include cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, diabetes, heart failure, a history of smoking, a poor ability to cough such as following a stroke, and a weak immune system. Diagnosis is often based on the symptoms and physical examination. Chest X-ray, blood tests, and culture of the sputum may help confirm the diagnosis. The disease may be classified by where it was acquired with community, hospital, or health care associated pneumonia.
Vaccines to prevent certain types of pneumonia are available. Other methods of prevention include handwashing and not smoking. Treatment depends on the underlying cause. Pneumonia believed to be due to bacteria is treated with antibiotics. If the pneumonia is severe, the affected person is generally hospitalized. Oxygen therapy may be used if oxygen levels are low.
Pneumonia affects approximately 450 million people globally (7% of the population) and results in about four million deaths per year. Pneumonia was regarded by William Osler in the 19th century as "the captain of the men of death". With the introduction of antibiotics and vaccines in the 20th century, survival improved. Nevertheless, in developing countries, and among the very old, the very young, and the chronically ill, pneumonia remains a leading cause of death. Pneumonia often shortens suffering among those already close to death and has thus been called "the old man's friend"
This is about tuberculosis , features, diagnosis and management. With reference to Uganda Clinical Guidelines
By Okeke Gloria, Kasule Steven, Sengooba Dennis Nyanzi
this presentation is based on national health program in india in relation to tuberculosis and malaria as these are mostly occuring disease in india so national program are organised to irradicate the spread of vector borne disease by various methods like controlling the vector (mosquitos) from spreading
role of community pharmacist in educating and monitoring of patients for infection and counselling and educating them regarding the control of malaria and tb.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
2. PULMONARY
TUBERCULOSIS
Tuberculosis is a bacterial disease caused
by Mycobacterium tuberculosis ( Tubercle
– lesion , Bacteria cause lesion so called
tubercle bacilli) .
Mycobacterium Tuberculi can affect any
part of bodies like meninges , kidney ,
bones and lymph nodes.
P Bhandari
3. Cont….
If it primarily affect the lungs parenchyma
, it is called pulmonary tuberculosis.
It is one of the major health and social
problems in Nepal.
It is characterized by pulmonary infiltrates
, formation of granulomas with fibrosis and
cavitation.
P Bhandari
5. INCIDENCE
o Incidence is highest in people who live in
crowded , poorly ventilated , unsanitary
conditions such as prisons , homeless
shelter etc.
o Leading cause of death in adults in Nepal
is 15 – 49 years.
o IN THE WORLD:
o Around one third of the world’s population
has tuberculosis and that between 2002
P Bhandari
6. Cont…
o And 2020 an estimated 1000 million people
will become newly infected .
o NEPAL :
o 5000 – 7000 people die from TB every year.
o Over 80,000 people in Nepal have diseases.
o 22,000 people have sputum positive TB every
years.
o 5000 – 7000 people die from TB every year.
P Bhandari
7. O CAUSATIVE AGENT : Mycobacterium
Tuberculosis.
O ROUTE OF INFECTION : Two species of
mycobacterium causes TB.
M. Tuberculosis - spreads by droplet
M. Bovis – transmitted by milk from diseased
cows
P Bhandari
8. CHARACTERISTICS
O Mycobacterium tuberculosis : Organism is rod
shaped , aerobic ( required oxygen to live )
O Non motile, gram positive acid fast micro
organism.
O Reproduce very slowly in human body.
O Destroyed by heat , burning , boiling for 15
minutes , autoclaving , pasteurizing .
P Bhandari
9. Cont…
O Ultraviolet rays are very effective and
strong Sun rays can also kill this
organism.
P Bhandari
10. PREDOSPOSING FACTOR
O Close contact of patient with smear positive
pulmonary tuberculosis.
O Malnutrition ; overcrowded population: prison
O Chest radiographic evidence of self healed TB
O Patients have immunosupression : HIV ,
Corticosteriods drugs , cytotoxic agents.
O Chronic renal failure ; Silicosis and deficiency
of vitamins A & D.
P Bhandari
11. RISK FACTOR
O Reason for the increasing incidence of TB
1. Developed Countries;
- Immigration from high prevalence areas
- Human immuno deficiency virus.
- Social deprivation ( homelessness , poverty )
- Increasing proportion of elderly
- Drug resistance
P Bhandari
12. Cont….
O 2. Developing Countries ;
- Ineffective control programmes.
- Lack of access to health care.
- Poverty , civil unrest.
- HIV , Population increase.
- Drug resistance.
P Bhandari
13. Factors increasing the risk of
TB
OPatient related
- Age ( children > young adult < elderly )
- Factors increasing the risk of TB.
- First generation immigrants from high
prevalence countries.
- Close contact of patients with smear positive
pulmonary TB.
- Overcrowding : prisons, collective
dormitories.
P Bhandari
14. Cont..
O Chest radiographic evidence of self healed
tuberculosis.
O Primary infection < 1 years previously.
O Associated Disease
O Immunosuppression – HIV , infliximab , high
dose corticosteroids , cytotoxic agents.
O Malignancy ( especially lymphoma and
leukaemia)
P Bhandari
15. Cont…
O Type 1 diabetes mellitus.
O Chronic real failure.
O Silicosis
O Gastrointestinal disease associated with
malnutrition ( gastrectomy , jejuno – ideal
bypass.
O Deficiency of vitamin D or A.
P Bhandari
16. PATHOPHYSIOLOGY
O When the bacilli is inhale Bacilli implant on
bronchioles or alveoli
O Multiply bacilli
Many bacilli engulfed by the macrophage.
Some remain viable and proliferate
Some bacilli spread either by lymph or blood
throughout body (Millary TB )
P Bhandari
17. Cont…
O Macrophages being to elongate and fuse
together to form an epithelium cell ,
tubercle which surround by lymphocytes (
formation of granuloma tubercle ).
O Granuloma tubercle transformed to fibrous
tissue mass , surrounding an area of
cessation lead to the appearance of the
primary lesion in the lung , referred to as
the ‘Ghon focus’
P Bhandari
18. Cont…
O The material ( Bacteria and microphages )
become necrotic forming a cheesy mass.
This mass may become calcified and form
a collagenous scar. At this point the
bacteria become dormant and there is no
further progression of active diseases.
P Bhandari
19. Cont…
O If inadequate immune system response,
the person may develop active disease. In
this case , the Ghon tubercle ulcerates,
releasing the cheesy material into the
bronchi. The cheesy material liquefies
may drain into the tracheobronchial trees
and may be coughed out. Cough out
continue , more than 2 weeks.
P Bhandari
20. Exposure to TB
No infection (70-90%)
Dormant TB (90%) well
-Never develop TB
NOT Infectious
Active TB (10%) ill
- 5% develop TB within 2 years
-% develop TB many years later
Infection (10 – 30 %)
P Bhandari
24. Diagnostic Procedure
O History and physical examination.
O Sputum smear examination for AFB : Time :
0,2,5,6 or 8 months.
O Samples are necessary. 2 sputum samples most be
positive for diagnosis of pulmonary TB.
O Chest X-ray :Not significant but it is supportive for
one smear positive TB.
O Sputum culture.
O Pleural biopsy, tissue biopsy from affected site.
P Bhandari
26. Tuberculin Test ( Mantoux
test )
O Low sensitivity , useful only in primary
infection.
O Purified Protein derivation ( PPD) is use
which is prepared by atypical mycobacteria.
O For mantoux test 0.1ml PPD is given
intradermally on the surface of forearm.
O The result of the test read after 72 hours.
O Tuberculin reactions consist of erythematic
and induration.
P Bhandari
27. Cont…
O Induration measure horizontally.
O Reactions exceeding 10mm are considered
positive; 6-9mm induration doubtful and less
than 6 negative.
P Bhandari
29. Treatment
According to DOTS- Directly Observed
Treatment
Short Course
Supervise therapy under the health personnel.
TB patient falls 2 categories.
Before starting the treatment, every patient
should be categorized.
P Bhandari
30. O Category 1:
New smear positive pulmonary TB,
severe ill extra pulmonary TB, Sputum smear negative
extra pulmonary TB.
Category 2:
Relapse , Treatment Failure, Default (
Interrupted treatment)
Common drugs used in DOTS
• Rifampicine (R) 150mg
• Isoniazide (H) 75 mg
• Streptomycin (S) .75-1gm
P Bhandari
31. • Pyrazinamide (Z) 400mg
• Ethambutol (E ) 400mg
Treatment regime on the basis of DOTS:
Category 1
Intensive Phase : 2 months, Drugs : HRZE
Continuation Phase : 4 months, Drugs : HR
Category 2
Intensive Phase: 3 months= 2 months SHRZE + 1
month HRZE
Continuation Phase: 5 months, Drugs HRE
P Bhandari
32. Drugs used
First Line Drugs Second Line
Drugs
Isoniazid Floroquinolones
Rifampicin Amino salicylic acid
Pyrazinamide Ethionamide
Streptomicin Capreomycin
Cycloserin
P Bhandari
33. Nursing Management
O Assessment: History taking, Personal history
, Physical examination – lungs consolidation
diminished bronchial sounds , crackles,
dullness on percussion.
Enlarged painful lymph nodes may be palpable.
P Bhandari
34. Nursing Diagnosis
O Infectiveness airway clearance related to copious
tracheobronchial secretion.
O Deficient knowledge related to treatment regimen.
O Activity intolerance related to fatigue, altered
nutritional status.
O Potential nursing diagnosis: Deficient knowledge
about side effect of medication.
O Deficient knowledge related to preventive
measures.
P Bhandari
35. Nursing Intervention
O Promoting airway clearance: Increase fluid
intake promotes systemic hydration and serves
as an effective expectorant.
O Instruct the patient about correct positioning.
O Instruct about postural drainage and give
steam inhalation.
P Bhandari
36. Advocate adherence to
treatment regimen
O Provide information and health education : TB
is communicable disease.
O DOTS is the most effective means of
prevention and curing of disease.
O Take medicine according to DOTS.
O Counseling to prevent treatment failure , return
after defaulter.
P Bhandari
37. Promoting Activities
O Chronic disease impaired nutritional status.
O Provide balance diet ; provide frequent meal,
plenty of fluid.
O Provide supplements of vitamins- Vitamin B
complex.
O Provide adequate protein diet.
O Plan a progress activity schedule that focuses
on increasing activity tolerance and muscle
strength.
P Bhandari
38. Monitor and Manage
O Complication
O Malnutrition
O Side effects of medications, lever function test
be done :-
- Give medicine in empty stomach , food affect
absorption.
- Rifampicin increase metabolism of B blockers,
anti – cougulants, oral contraceptic pill ,
digoxin, verapamil.
P Bhandari
39. Cont..
- Inform patient that rifampicin discolours urine,
colours eyes lens.
- Monitor for liver and kidney function.
o Sputum culture to see response and adherence to
therapy.
o Isoniazide : Peripherial neuritis.
o Streptomycin : Tinnitus
o Pyrazinamide : Hepatotoxicity ; jaundice
o Ethambutol : Blurred Vision ( visual disturbance)
P Bhandari
40. Provide Information on
Disease Prevention
O Milk parturition and milk boiling , do not take
raw milk.
O Compliance of treatment ( 1 sputum +ve TB
can transmit disease to 10-15 person each
year) so complete continue treatment is very
important.
P Bhandari
41. Cont…
O Protection against exposure to TB: well
ventilated room , hospital wards, offices. Good
ventilation helps reduce TB transmission.
Sunlight is a source of ultraviolet light which
can kill TB bacilli.
O Sputum disposes properly – use sputum pots
with lids, covering the mouth with hands when
coughing, sneezing.
P Bhandari
42. Cont..
O Use mask for preventing droplet enter into the
lungs.
O Give BCG vaccination to all children to
prevent tuberculosis.
O Prevention of malnutrition.
O Promote environmental sanitation , reduce
overcrowded.
P Bhandari